June 6, 2025
1
min read
Exciting news for sleep health in Australia! The TGA has just approved Mounjaro (tirzepatide) for the treatment of obstructive sleep apnoea (OSA). This marks a major step forward in expanding treatment options for people living with OSA. Talk to your healthcare provider to learn more about what this could mean for you or your loved ones.
Dr Moira Junge, Sleep Health Foundation CEO, spoke to 9 News about the announcement.